IL6 and COVID-19: In alleviating syndrome of COVID-19, the usage of glucocorticoid hormones can inhibit inflammation and cytokine storm and thus, improve the condition of severe COVID-19 patients by (re)activating ACE2 and reducing interleukin (IL)-6 levels (74).